Welcome to our dedicated page for Keycorp SEC filings (Ticker: KEY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The KeyCorp (NYSE: KEY) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, with AI-powered tools to help interpret complex documents. KeyCorp, an Ohio-incorporated bank-based financial services company headquartered in Cleveland, files a range of forms that describe its financial condition, capital structure, and significant corporate events.
Investors researching KeyCorp’s periodic results can use this page to locate quarterly and annual reports, where the company presents consolidated balance sheets, statements of income, and detailed discussions of net interest income, noninterest income categories, expenses, loans, deposits, and asset quality. These filings expand on the metrics highlighted in earnings press releases and provide context for trends in areas such as commercial and consumer lending, deposit mix, and credit performance.
The filings list also includes current reports on Form 8-K, which KeyCorp uses to disclose material events. Recent 8-K filings have covered topics such as quarterly earnings announcements, investor presentations, the redemption of senior bank notes issued by KeyBank National Association, and the registration of common shares issued under an investment agreement. These documents help explain how KeyCorp manages its capital, funding, and investor communications.
Users interested in capital structure and securities can find information on KeyCorp’s common shares and multiple series of preferred stock, which are represented by depositary shares trading on the New York Stock Exchange. Filings detail the registration of these securities and related legal opinions. Form 4 and similar insider transaction reports, when available, allow closer monitoring of trading activity by directors and officers.
Stock Titan’s interface enhances these filings with AI-generated summaries that highlight key points, clarify technical language, and surface important sections of lengthy documents. Real-time updates from EDGAR mean new KeyCorp filings appear promptly, while filters make it easier to focus on specific form types such as 10-K, 10-Q, 8-K, or insider ownership reports.
KeyCorp is planning to issue a new series of senior medium‑term notes under its Series S program. These unsecured fixed‑to‑floating rate notes will pay a fixed interest rate from issuance until one year before maturity in 2037, then switch to a floating rate tied to Compounded SOFR plus a spread. The notes rank equally with KeyCorp’s other senior unsecured debt and are not insured by the FDIC or any government agency.
KeyCorp may redeem the notes early, including via a make‑whole call before a specified par call date and at par closer to maturity. The company intends to use net proceeds for general corporate purposes, including funding needs at KeyCorp and its subsidiaries, with temporary investment in highly liquid short‑term securities. The filing highlights structural subordination to subsidiary debt and detailed risks tied to floating‑rate benchmarks such as SOFR and EURIBOR.
KeyCorp furnished its financial results for the three- and twelve-month periods ended December 31, 2025, and announced several board changes. The company issued a press release and a supplemental information package outlining fourth quarter 2025 performance, and filed its consolidated balance sheets and statements of income as part of the report. Two long-serving directors, Ruth Ann Gillis and Carlton Highsmith, plan to retire from the board at the 2026 Annual Meeting of Shareholders. The board intends to nominate Antonio "Tony" DeSpirito and Christopher L. "Chris" Henson as independent directors at that meeting, keeping the board size at 14 members. KeyCorp also named Todd Vasos as Lead Independent Director, succeeding Alexander M. "Sandy" Cutler, who remains on the board.
KeyCorp reported that Board member David K. Wilson has retired from its Board of Directors for personal health reasons, effective January 13, 2026. In connection with his departure, the Board approved a reduction in its size to 14 members, effective January 15, 2026. This change reflects an adjustment in the Board’s composition following Mr. Wilson’s immediate retirement.
KeyCorp director reports deferred share distributions and holdings update. On 01/01/2026, a KeyCorp director converted deferred shares into common shares in two transactions. The director acquired 1,526 common shares and 1,377 common shares through the exercise of deferred share rights that are the economic equivalent of common shares under the KeyCorp Second Directors' Deferred Compensation Plan and related arrangements.
Following these transactions, the director beneficially owned 77,787 and 79,164 common shares in direct form, as well as 10,683 and 178,885 deferred shares. The filing notes these amounts include dividend reinvestments and dividend-equivalent deferred shares credited in December 2025, and that certain deferred shares will be distributed in ten quarterly installments beginning on July 1, 2025.
KeyCorp director Todd J. Vasos reported equity holdings and a compensation-related share deferral. As of a transaction dated 12/31/2025, he held 35,255 KeyCorp common shares directly. In addition, he acquired 1,574 deferred shares under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan, at a reference price of $20.64 per deferred share.
The deferred shares are described as the economic equivalent of common shares, with payment deferred until the earlier of January 1, 2027 or the director's death. Following this transaction, Vasos held 65,087 derivative securities tied to common shares, which include approximately 630 dividend-equivalent deferred shares that accrued in December 2025.
KeyCorp director reports share disposition and deferral of fees into stock-based compensation plan. A KeyCorp director reported a transaction dated 12/31/2025 involving 750 common shares disposed of. The director also acquired 1,453 deferred share units at a reference price of $20.64, each economically equivalent to a KeyCorp common share, under the company’s Amended and Restated Directors' Deferred Share Sub-Plan to the 2019 Equity Compensation Plan.
Following these transactions, the director beneficially owned 76,711 derivative securities in the form of deferred shares. Payment of these deferred shares has been postponed until the earlier of January 1, 2027, or the director’s death, and this total includes approximately 747 dividend-equivalent deferred shares accrued in December 2025.
KeyCorp director reports equity award activity involving deferred shares and common stock. On 01/01/2026, the reporting person converted 8,635 Deferred Shares into 8,635 Common Shares, resulting in 59,506 Common Shares beneficially owned directly after this transaction. On 01/02/2026, an additional 1,703 Deferred Shares were converted into 1,703 Common Shares, increasing direct beneficial ownership to 61,209 Common Shares.
The person also continues to hold derivative positions in Deferred Shares. After the 01/01/2026 transaction, 58,922 Deferred Shares were beneficially owned, and after the 01/02/2026 transaction, 57,219 Deferred Shares remained. Each Deferred Share is the economic equivalent of one Common Share, and the derivative holdings include approximately 2,246 dividend-equivalent Deferred Shares accrued under a Deferred Share Plan between June and December 2025.
KeyCorp director Elizabeth R. Gile reported a share conversion on Form 4. On 01/01/2026, 4,319 Deferred Shares were converted (transaction code M) into the same number of KeyCorp common shares. Following this transaction, she directly owned 45,201 common shares.
The report also shows continued ownership of 123,368 Deferred Shares, each of which is the economic equivalent of one common share. This Deferred Share balance includes approximately 4,244 dividend-equivalent Deferred Shares that accrued between June 2025 and December 2025.
KeyCorp director Alexander M. Cutler reported an update to his equity holdings in the company. On 12/31/2025, he acquired 1,090 deferred shares under KeyCorp’s Amended and Restated Directors' Deferred Share Sub-Plan, at a reference price of $20.64 per underlying common share. These deferred shares represent directors’ fees that have been converted into the economic equivalent of common shares.
Under the plan, payment of the deferred shares is postponed until the earlier of July 1, 2028 or the director’s death. After this transaction, Cutler beneficially owned 298,416 common shares directly and 56,370 deferred shares, which include approximately 548 dividend-equivalent deferred shares accrued in December 2025.
KeyCorp director Devina A. Rankin reported a fee deferral transaction involving deferred share units tied to KeyCorp common shares. On 12/31/2025, Rankin acquired 1,453 deferred shares under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan at a conversion price of $20.64 per underlying common share. These deferred shares are described as the economic equivalent of common shares, with payment deferred until the earlier of January 1, 2031, or the director’s death. Following this transaction, Rankin beneficially owned 79,346 derivative deferred shares, which includes approximately 773 dividend-equivalent deferred shares accrued in December 2025, and 13,430 common shares held directly.